<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39599883</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1769</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16111769</ELocationID><Abstract><AbstractText>COVID-19 can range from a mild to severe acute respiratory syndrome and also could result in multisystemic damage. Additionally, many people develop post-acute symptoms associated with immune and metabolic disturbances in response to viral infection, requiring longitudinal and multisystem studies to understand the complexity of COVID-19 pathophysiology. Here, we conducted a <sup>1</sup>H Nuclear Magnetic Resonance metabolomics in saliva of symptomatic subjects presenting mild and moderate respiratory symptoms to investigate prospective changes in the metabolism induced after acute-phase SARS-CoV-2 infection. Saliva from 119 donors presenting non-COVID and COVID-19 respiratory symptoms were evaluated in the acute phase (T1) and the post-acute phase (T2). We found two clusters of metabolite fluctuation in the COVID-19 group. Cluster 1, metabolites such as glucose, (CH<sub>3</sub>)<sub>3</sub> choline-related metabolites, 2-hydroxybutyrate, BCAA, and taurine increased in T2 relative to T1, and in cluster 2, acetate, creatine/creatinine, phenylalanine, histidine, and lysine decreased in T2 relative to T1. Metabolic fluctuations in the COVID-19 group were associated with overweight/obesity, vaccination status, higher viral load, and viral clearance of the respiratory tract. Our data unveil metabolic signatures associated with the transition to the post-acute phase of SARS-CoV-2 infection that may reflect tissue damage, inflammatory process, and activation of tissue repair cascade. Thus, they contribute to describing alterations in host metabolism that may be associated with prolonged symptoms of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendes</LastName><ForeName>Luiza Tom&#xe9;</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>LaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de G&#xf3;es, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama-Almeida</LastName><ForeName>Marcos C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-7995-447X</Identifier><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reis</LastName><ForeName>Desir&#xe9;e Lopes</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Ana Carolina Pires E</ForeName><Initials>ACPE</Initials><AffiliationInfo><Affiliation>LaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de G&#xf3;es, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neris</LastName><ForeName>R&#xf4;mulo Le&#xe3;o Silva</ForeName><Initials>RLS</Initials><Identifier Source="ORCID">0000-0002-7436-1680</Identifier><AffiliationInfo><Affiliation>LaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de G&#xf3;es, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galliez</LastName><ForeName>Rafael Mello</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>N&#xfa;cleo de Enfrentamento e Estudos de Doen&#xe7;as Infecciosas Emergentes e Reemergentes (NEEDIER), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-599, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casti&#xf1;eiras</LastName><ForeName>Terezinha Marta Pereira Pinto</ForeName><Initials>TMPP</Initials><Identifier Source="ORCID">0000-0002-4746-6049</Identifier><AffiliationInfo><Affiliation>N&#xfa;cleo de Enfrentamento e Estudos de Doen&#xe7;as Infecciosas Emergentes e Reemergentes (NEEDIER), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-599, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>On Behalf Of The Ufrj Covid-Working Group</LastName></Author><Author ValidYN="Y"><LastName>Ludwig</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8901-6970</Identifier><AffiliationInfo><Affiliation>Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0001-7219-1123</Identifier><AffiliationInfo><Affiliation>National Center for Nuclear Magnetic Resonance-Jiri Jonas, Institute of Medical Biochemistry, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa Dos Santos Junior</LastName><ForeName>Gilson</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2038-2267</Identifier><AffiliationInfo><Affiliation>LabMet-Laboratory of Metabolomics, Instituto de Biologia Roberto Alcantara Gomes (IBRAG), Department of Genetics, State University of Rio de Janeiro, Rio de Janeiro 20551-030, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Bacha</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0809-0218</Identifier><AffiliationInfo><Affiliation>LeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josu&#xe9; de Castro, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assun&#xe7;&#xe3;o-Miranda</LastName><ForeName>Iranaia</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5684-4788</Identifier><AffiliationInfo><Affiliation>LaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de G&#xf3;es, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>E-26/210.658/2021</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro</Agency><Country/></Grant><Grant><GrantID>E-26/211.509/2021</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro</Agency><Country/></Grant><Grant><GrantID>E-26/201.152/2022</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro</Agency><Country/></Grant><Grant><GrantID>E-26/210.785/2021</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro</Agency><Country/></Grant><Grant><GrantID>01.20.0029.000462/20</GrantID><Agency>Financiadora de Estudos e Projetos</Agency><Country/></Grant><Grant><GrantID>404096/2020-4</GrantID><Agency>National Council for Scientific and Technological Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="Y">Saliva</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066244" MajorTopicYN="N">Proton Magnetic Resonance Spectroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">metabolic fluctuation</Keyword><Keyword MajorTopicYN="N">metabolome</Keyword><Keyword MajorTopicYN="N">saliva</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39599883</ArticleId><ArticleId IdType="doi">10.3390/v16111769</ArticleId><ArticleId IdType="pii">v16111769</ArticleId><ArticleId IdType="pmc">PMC11598993</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rodriguez-Morales A.J., Lopez-Echeverri M.C., Perez-Raga M.F., Quintero-Romero V., Valencia-Gallego V., Galindo-Herrera N., L&#xf3;pez-Alzate S., S&#xe1;nchez-Vinasco J.D., Guti&#xe9;rrez-Vargas J.J., Mayta-Tristan P., et al. The Global Challenges of the Long COVID-19 in Adults and Children. Travel Med. Infect. Dis. 2023;54:102606. doi: 10.1016/j.tmaid.2023.102606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2023.102606</ArticleId><ArticleId IdType="pmc">PMC10247301</ArticleId><ArticleId IdType="pubmed">37295581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushwaha N.D., Mohan J., Kushwaha B., Ghazi T., Nwabuife J.C., Koorbanally N., Chuturgoon A.A. A Comprehensive Review on the Global Efforts on Vaccines and Repurposed Drugs for Combating COVID-19. Eur. J. Med. Chem. 2023;260:115719. doi: 10.1016/j.ejmech.2023.115719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2023.115719</ArticleId><ArticleId IdType="pubmed">37597435</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.A. A Review of SARS-CoV-2 Variants and Vaccines: Viral Properties, Mutations, Vaccine Efficacy, and Safety. Infect. Med. 2023;2:247&#x2013;261. doi: 10.1016/j.imj.2023.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imj.2023.08.005</ArticleId><ArticleId IdType="pmc">PMC10774670</ArticleId><ArticleId IdType="pubmed">38205179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., Terpos E., Dimopoulos M.A. Organ-Specific Manifestations of COVID-19 Infection. Clin. Exp. Med. 2020;20:493&#x2013;506. doi: 10.1007/s10238-020-00648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00648-x</ArticleId><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 Pathogenesis. Nat. Rev. Microbiol. 2022;20:270&#x2013;284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun M.C., Singh A.K., Pal D., Das K., G. A., Venkateshan M., Mishra B., Patro B.K., Mohapatra P.R., Subba S.H. Characteristics and Predictors of Long COVID among Diagnosed Cases of COVID-19. PLoS ONE. 2022;17:e0278825. doi: 10.1371/journal.pone.0278825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Caz&#xe9; A.B., Cerqueira-Silva T., Bomfim A.P., de Souza G.L., Azevedo A.C., Brasil M.Q., Santos N.R., Khouri R., Dan J., Bandeira A.C., et al. Prevalence and Risk Factors for Long COVID after Mild Disease: A Cohort Study with a Symptomatic Control Group. J. Glob. Health. 2023;13:06015. doi: 10.7189/jogh.13.06015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.06015</ArticleId><ArticleId IdType="pmc">PMC10173895</ArticleId><ArticleId IdType="pubmed">37166260</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The Immunology of Long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer P.E., Kirwan J.P., Rosen C.J. Post-Acute Sequelae of COVID-19: A Metabolic Perspective. Elife. 2022;11:e78200. doi: 10.7554/eLife.78200.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78200</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Gama-Almeida M.C., Pinto G.D.A., Teixeira L., Hottz E.D., Ivens P., Ribeiro H., Garrett R., Torres A.G., Carneiro T.I.A., Barbalho B.d.O., et al. Integrated NMR and MS Analysis of the Plasma Metabolome Reveals Major Changes in One-Carbon, Lipid, and Amino Acid Metabolism in Severe and Fatal Cases of COVID-19. Metabolites. 2023;13:879. doi: 10.3390/metabo13070879.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13070879</ArticleId><ArticleId IdType="pmc">PMC10384698</ArticleId><ArticleId IdType="pubmed">37512587</ArticleId></ArticleIdList></Reference><Reference><Citation>Karu N., Kindt A., van Gammeren A.J., Ermens A.A.M., Harms A.C., Portengen L., Vermeulen R.C.H., Dik W.A., Langerak A.W., van der Velden V.H.J., et al. Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress. Metabolites. 2022;12:618. doi: 10.3390/metabo12070618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070618</ArticleId><ArticleId IdType="pmc">PMC9321395</ArticleId><ArticleId IdType="pubmed">35888742</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares N.C., Hussein A., Muhammad J.S., Semreen M.H., ElGhazali G., Hamad M. Plasma Metabolomics Profiling Identifies New Predictive Biomarkers for Disease Severity in COVID-19 Patients. PLoS ONE. 2023;18:e0289738. doi: 10.1371/journal.pone.0289738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0289738</ArticleId><ArticleId IdType="pmc">PMC10414581</ArticleId><ArticleId IdType="pubmed">37561777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan M.R., Suleiman M., P&#xe9;rez-L&#xf3;pez A. Metabolomics in the Diagnosis and Prognosis of COVID-19. Front. Genet. 2021;12:721556. doi: 10.3389/fgene.2021.721556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.721556</ArticleId><ArticleId IdType="pmc">PMC8343128</ArticleId><ArticleId IdType="pubmed">34367265</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Mon&#xe1;rrez-Espino J., L&#xf3;pez D.A.G., Zheng J., Borrego J.C., Torres-Calzada C., Elizalde-D&#xed;az J.P., Mandal R., Berjanskii M., Mart&#xed;nez-Mart&#xed;nez E., et al. The Plasma Metabolome of Long COVID Patients Two Years after Infection. Sci. Rep. 2023;13:12420. doi: 10.1038/s41598-023-39049-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L., Ben Nasr M., D&#x2019;Addio F., Loretelli C., Rossi A., Pastore I., Daniele G., Abdelsalam A., Maestroni A., Dell&#x2019;Acqua M., et al. Acute and Long-Term Disruption of Glycometabolic Control after SARS-CoV-2 Infection. Nat. Metab. 2021;3:774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and Burdens of Incident Diabetes in Long COVID: A Cohort Study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyv&#xe4;rinen E., Savolainen M., Mikkonen J.J.W., Kullaa A.M. Salivary Metabolomics for Diagnosis and Monitoring Diseases: Challenges and Possibilities. Metabolites. 2021;11:587. doi: 10.3390/metabo11090587.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11090587</ArticleId><ArticleId IdType="pmc">PMC8469343</ArticleId><ArticleId IdType="pubmed">34564402</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa dos Santos Junior G., Pereira C.M., Kelly da Silva Fidalgo T., Valente A.P. Saliva NMR-Based Metabolomics in the War Against COVID-19. Anal. Chem. 2020;92:15688&#x2013;15692. doi: 10.1021/acs.analchem.0c04679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c04679</ArticleId><ArticleId IdType="pubmed">33215503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A., Sun H., Wang X. Saliva Metabolomics Opens Door to Biomarker Discovery, Disease Diagnosis, and Treatment. Appl. Biochem. Biotechnol. 2012;168:1718&#x2013;1727. doi: 10.1007/s12010-012-9891-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12010-012-9891-5</ArticleId><ArticleId IdType="pubmed">22971835</ArticleId></ArticleIdList></Reference><Reference><Citation>Castineiras T.M.P.P., Nascimento &#xc9;.R.d.S., Faffe D.S., Galliez R.M., Mariani D., Leit&#xe3;o I.d.C., de Melo M.G.M., Ferreira O.C., Tanuri A. Performance of an Alternative RT-PCR Procedure Using Residual Sample from the PanbioTM Ag COVID-19 Test. Braz. J. Infect. Dis. 2021;25:101630. doi: 10.1016/j.bjid.2021.101630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2021.101630</ArticleId><ArticleId IdType="pmc">PMC8506141</ArticleId><ArticleId IdType="pubmed">34648741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang T.L., Shaka A.J. Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients. J. Magn. Reson. A. 1995;112:275&#x2013;279. doi: 10.1006/jmra.1995.1047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmra.1995.1047</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr H.Y., Purcell E.M. Effects of Diffusion on Free Precession in Nuclear Magnetic Resonance Experiments. Phys. Rev. 1954;94:630&#x2013;638. doi: 10.1103/PhysRev.94.630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRev.94.630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig C., G&#xfc;nther U.L. MetaboLab&#x2014;Advanced NMR Data Processing and Analysis for Metabolomics. BMC Bioinform. 2011;12:366. doi: 10.1186/1471-2105-12-366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-366</ArticleId><ArticleId IdType="pmc">PMC3179975</ArticleId><ArticleId IdType="pubmed">21914187</ArticleId></ArticleIdList></Reference><Reference><Citation>Savorani F., Tomasi G., Engelsen S.B. Icoshift: A Versatile Tool for the Rapid Alignment of 1D NMR Spectra. J. Magn. Reson. 2010;202:190&#x2013;202. doi: 10.1016/j.jmr.2009.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmr.2009.11.012</ArticleId><ArticleId IdType="pubmed">20004603</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinette S.L., Zhang F., Br&#xfc;schweiler-Li L., Br&#xfc;schweiler R. Web Server Based Complex Mixture Analysis by NMR. Anal. Chem. 2008;80:3606&#x2013;3611. doi: 10.1021/ac702530t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac702530t</ArticleId><ArticleId IdType="pubmed">18422338</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart D.S., Feunang Y.D., Marcu A., Guo A.C., Liang K., V&#xe1;zquez-Fresno R., Sajed T., Johnson D., Li C., Karu N., et al. HMDB 4.0: The Human Metabolome Database for 2018. Nucleic Acids Res. 2018;46:D608&#x2013;D617. doi: 10.1093/nar/gkx1089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1089</ArticleId><ArticleId IdType="pmc">PMC5753273</ArticleId><ArticleId IdType="pubmed">29140435</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong J., Wishart D.S., Xia J. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis. Curr. Protoc. Bioinform. 2019;68:e86. doi: 10.1002/cpbi.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpbi.86</ArticleId><ArticleId IdType="pubmed">31756036</ArticleId></ArticleIdList></Reference><Reference><Citation>Atila A., Alay H., Yaman M.E., Akman T.C., Cadirci E., Bayrak B., Celik S., Atila N.E., Yaganoglu A.M., Kadioglu Y., et al. The Serum Amino Acid Profile in COVID-19. Amino Acids. 2021;53:1569&#x2013;1588. doi: 10.1007/s00726-021-03081-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-021-03081-w</ArticleId><ArticleId IdType="pmc">PMC8487804</ArticleId><ArticleId IdType="pubmed">34605988</ArticleId></ArticleIdList></Reference><Reference><Citation>Liptak P., Baranovicova E., Rosolanka R., Simekova K., Bobcakova A., Vysehradsky R., Duricek M., Dankova Z., Kapinova A., Dvorska D., et al. Persistence of Metabolomic Changes in Patients during Post-COVID Phase: A Prospective, Observational Study. Metabolites. 2022;12:641. doi: 10.3390/metabo12070641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070641</ArticleId><ArticleId IdType="pmc">PMC9321209</ArticleId><ArticleId IdType="pubmed">35888766</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco A.C.C.C., Yoshikawa F.S.Y., Pietrobon A.J., Sato M.N. Role of Histamine in Modulating the Immune Response and Inflammation. Mediat. Inflamm. 2018;2018:1&#x2013;10. doi: 10.1155/2018/9524075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/9524075</ArticleId><ArticleId IdType="pmc">PMC6129797</ArticleId><ArticleId IdType="pubmed">30224900</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Fidalgo T.K., Freitas-Fernandes L.B., Marques B.B.F., de Ara&#xfa;jo C.S., da Silva B.J., Guimar&#xe3;es T.C., Fischer R.G., Tinoco E.M.B., Valente A.P. Salivary Metabolomic Analysis Reveals Amino Acid Metabolism Shift in SARS-CoV-2 Virus Activity and Post-Infection Condition. Metabolites. 2023;13:263. doi: 10.3390/metabo13020263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13020263</ArticleId><ArticleId IdType="pmc">PMC9962089</ArticleId><ArticleId IdType="pubmed">36837882</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang H., Liu Q.-P. Alterations of the Gut Microbiota in Coronavirus Disease 2019 and Its Therapeutic Potential. World J. Gastroenterol. 2022;28:6689&#x2013;6701. doi: 10.3748/wjg.v28.i47.6689.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i47.6689</ArticleId><ArticleId IdType="pmc">PMC9813939</ArticleId><ArticleId IdType="pubmed">36620345</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C.-Y., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut Microbiota Composition Reflects Disease Severity and Dysfunctional Immune Responses in Patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi C., Levi R., Braga D., Carli F., Darwich A., Spadoni I., Oresta B., Dioguardi C.C., Peano C., Ubaldi L., et al. A &#x2018;Multiomic&#x2019; Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019. Gastro Hep Adv. 2022;1:194&#x2013;209. doi: 10.1016/j.gastha.2021.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastha.2021.12.006</ArticleId><ArticleId IdType="pmc">PMC8818445</ArticleId><ArticleId IdType="pubmed">35174369</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bradley E., Zeamer A.L., Cincotta L., Salive M.-C., Dutta P., Mutaawe S., Anya O., Meza-Segura M., Moormann A.M., et al. Inflammation-Type Dysbiosis of the Oral Microbiome Associates with the Duration of COVID-19 Symptoms and Long COVID. JCI Insight. 2021;6:e152346. doi: 10.1172/jci.insight.152346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W., Rohli K.E., Yang S., Jia P. Impact of Obesity on COVID-19 Patients. J. Diabetes Complicat. 2021;35:107817. doi: 10.1016/j.jdiacomp.2020.107817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2020.107817</ArticleId><ArticleId IdType="pmc">PMC7690270</ArticleId><ArticleId IdType="pubmed">33358523</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective Effect of COVID-19 Vaccination against Long COVID Syndrome: A Systematic Review and Meta-Analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam I.C.H., Zhang R., Man K.K.C., Wong C.K.H., Chui C.S.L., Lai F.T.T., Li X., Chan E.W.Y., Lau C.S., Wong I.C.K., et al. Persistence in Risk and Effect of COVID-19 Vaccination on Long-Term Health Consequences after SARS-CoV-2 Infection. Nat. Commun. 2024;15:1716. doi: 10.1038/s41467-024-45953-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-45953-1</ArticleId><ArticleId IdType="pmc">PMC10894867</ArticleId><ArticleId IdType="pubmed">38403654</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo A.C., Davanzo G.G., de Brito Monteiro L., de Souza G.F., Muraro S.P., Virgilio-da-Silva J.V., Prodonoff J.S., Carregari V.C., de Biagi Junior C.A.O., Crunfli F., et al. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1&#x3b1;/Glycolysis-Dependent Axis. Cell Metab. 2020;32:437&#x2013;446.e5. doi: 10.1016/j.cmet.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Li C., Xu Y., He B., Hu M., Cao G., Li L., Wu S., Wang X., Zhang C., et al. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019. Mediat. Inflamm. 2021;2021:1&#x2013;9. doi: 10.1155/2021/8812304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8812304</ArticleId><ArticleId IdType="pmc">PMC7977979</ArticleId><ArticleId IdType="pubmed">33814982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D., Yan R., Lv L., Jiang H., Lu Y., Sheng J., Xie J., Wu W., Xia J., Xu K., et al. The Serum Metabolome of COVID-19 Patients Is Distinctive and Predictive. Metabolism. 2021;118:154739. doi: 10.1016/j.metabol.2021.154739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154739</ArticleId><ArticleId IdType="pmc">PMC7920809</ArticleId><ArticleId IdType="pubmed">33662365</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto E.A., Cruz A.S., Veras F.P., Martins R., Bernardelli R.S., Paiva I.M., Lima T.M., Singh Y., Guimar&#xe3;es R.C., Damasceno S., et al. COVID-19-Related Hyperglycemia Is Associated with Infection of Hepatocytes and Stimulation of Gluconeogenesis. Proc. Natl. Acad. Sci. USA. 2023;120:e2217119120. doi: 10.1073/pnas.2217119120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2217119120</ArticleId><ArticleId IdType="pmc">PMC10214153</ArticleId><ArticleId IdType="pubmed">37186819</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahrooz A., Muscogiuri G., Buzzetti R., Maddaloni E. The Complex Combination of COVID-19 and Diabetes: Pleiotropic Changes in Glucose Metabolism. Endocrine. 2021;72:317&#x2013;325. doi: 10.1007/s12020-021-02729-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02729-7</ArticleId><ArticleId IdType="pmc">PMC8060688</ArticleId><ArticleId IdType="pubmed">33886062</ArticleId></ArticleIdList></Reference><Reference><Citation>Heald A.H., Stedman M., Horne L., Rea R., Whyte M., Gibson J.M., Anderson S.G., Ollier W. The Change in Glycaemic Control Immediately after COVID-19 Vaccination in People with Type 1 Diabetes. Diabet. Med. 2022;39:e14774. doi: 10.1111/dme.14774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.14774</ArticleId><ArticleId IdType="pubmed">34936128</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Garc&#xed;a F.J., P&#xe9;rez-Hern&#xe1;ndez C.A., Rodr&#xed;guez-Murillo M., Moreno-Altamirano M.M.B. The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections. Front. Cell. Infect. Microbiol. 2021;11:725043. doi: 10.3389/fcimb.2021.725043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.725043</ArticleId><ArticleId IdType="pmc">PMC8476952</ArticleId><ArticleId IdType="pubmed">34595133</ArticleId></ArticleIdList></Reference><Reference><Citation>Timpani C.A., Rybalka E. Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19. Pharmaceuticals. 2020;14:15. doi: 10.3390/ph14010015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14010015</ArticleId><ArticleId IdType="pmc">PMC7824470</ArticleId><ArticleId IdType="pubmed">33375288</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Carroll S.M., O&#x2019;Neill L.A.J. Targeting Immunometabolism to Treat COVID-19. Immunother. Adv. 2021;1:ltab013. doi: 10.1093/immadv/ltab013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/immadv/ltab013</ArticleId><ArticleId IdType="pmc">PMC8195165</ArticleId><ArticleId IdType="pubmed">34240083</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D., Farahani E., Thyrsted J., Blay-Cadanet J., Herengt A., Idorn M., Hait A., Hernaez B., Knudsen A., Iversen M.B., et al. SARS-CoV2-Mediated Suppression of NRF2-Signaling Reveals Potent Antiviral and Anti-Inflammatory Activity of 4-Octyl-Itaconate and Dimethyl Fumarate. Nat. Commun. 2020;11:4938. doi: 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18764-3</ArticleId><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahnavard A., Mann B., Giri A., Chatterjee R., Crandall K.A. Metabolite, Protein, and Tissue Dysfunction Associated with COVID-19 Disease Severity. Sci. Rep. 2022;12:12204. doi: 10.1038/s41598-022-16396-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-16396-9</ArticleId><ArticleId IdType="pmc">PMC9288092</ArticleId><ArticleId IdType="pubmed">35842456</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;ez-Franco J.C., Torres-Ruiz J., Sosa-Hern&#xe1;ndez V.A., Cervantes-D&#xed;az R., Romero-Ram&#xed;rez S., P&#xe9;rez-Fragoso A., Meza-S&#xe1;nchez D.E., Germ&#xe1;n-Acacio J.M., Maravillas-Montero J.L., Mej&#xed;a-Dom&#xed;nguez N.R., et al. Metabolomics Analysis Reveals a Modified Amino Acid Metabolism That Correlates with Altered Oxygen Homeostasis in COVID-19 Patients. Sci. Rep. 2021;11:6350. doi: 10.1038/s41598-021-85788-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85788-0</ArticleId><ArticleId IdType="pmc">PMC7973513</ArticleId><ArticleId IdType="pubmed">33737694</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur V.P., Nemkov T., de Boer E., Mohning M.P., Baraghoshi D., Cendali F.I., San-Mill&#xe1;n I., Petrache I., D&#x2019;Alessandro A. Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J.A., Nemkov T., Bertolone L., Francis R.O., Hudson K.E., Zimring J.C., Hansen K.C., Hod E.A., et al. COVID-19 Infection Alters Kynurenine and Fatty Acid Metabolism, Correlating with IL-6 Levels and Renal Status. JCI Insight. 2020;5:e140327. doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T., Jurinovic V., Arnreich C., Lipworth B.J., Hellmuth J.C., von Bergwelt-Baildon M., Klein M., Weinberger T. Elevated Levels of IL-6 and CRP Predict the Need for Mechanical Ventilation in COVID-19. J. Allergy Clin. Immunol. 2020;146:128&#x2013;136.e4. doi: 10.1016/j.jaci.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7233239</ArticleId><ArticleId IdType="pubmed">32425269</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia B.S.B., Ferreira V.G., Piagge P.M.F.D., Almeida M.B., Assun&#xe7;&#xe3;o N.A., Raimundo J.R.S., Fonseca F.L.A., Carrilho E., Cardoso D.R. 1H QNMR-Based Metabolomics Discrimination of Covid-19 Severity. J. Proteome Res. 2022;21:1640&#x2013;1653. doi: 10.1021/acs.jproteome.1c00977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00977</ArticleId><ArticleId IdType="pubmed">35674498</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liu Y., Xu G., Xie Y., Wang X., Wu J., Chen H. Plasma Metabolomic Characterization of SARS-CoV-2 Omicron Infection. Cell Death Dis. 2023;14:276. doi: 10.1038/s41419-023-05791-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-023-05791-3</ArticleId><ArticleId IdType="pmc">PMC10113737</ArticleId><ArticleId IdType="pubmed">37076483</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., Quan S., Zhang F., Sun R., Qian L., et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59&#x2013;72.e15. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>